Albert Esquirol

945 total citations
45 papers, 433 citations indexed

About

Albert Esquirol is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Albert Esquirol has authored 45 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 20 papers in Oncology and 11 papers in Immunology. Recurrent topics in Albert Esquirol's work include Hematopoietic Stem Cell Transplantation (32 papers), Polyomavirus and related diseases (13 papers) and Lymphoma Diagnosis and Treatment (9 papers). Albert Esquirol is often cited by papers focused on Hematopoietic Stem Cell Transplantation (32 papers), Polyomavirus and related diseases (13 papers) and Lymphoma Diagnosis and Treatment (9 papers). Albert Esquirol collaborates with scholars based in Spain, United States and Italy. Albert Esquirol's co-authors include Rodrigo Martino, Jorge Sierra, Irene García‐Cadenas, Pere Barba, David Valcárcel, Salut Brunet, Javier Briones, Silvana Novelli, José Luís Piñana and Ana Garrido and has published in prestigious journals such as Blood, AIDS and British Journal of Haematology.

In The Last Decade

Albert Esquirol

41 papers receiving 431 citations

Peers

Countries citing papers authored by Albert Esquirol

Since Specialization

Citations

This map shows the geographic impact of Albert Esquirol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Esquirol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Esquirol more than expected).

Fields of papers citing papers by Albert Esquirol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Esquirol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Esquirol. The network helps show where Albert Esquirol may publish in the future.

Co-authorship network of co-authors of Albert Esquirol

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Esquirol. A scholar is included among the top collaborators of Albert Esquirol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Esquirol. Albert Esquirol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma 2025 ·Blood ·A Caballero, (unknown), (unknown), (unknown), (unknown), (unknown), Irene García‐Cadenas, Albert Esquirol, Rodrigo Martino, (unknown), (unknown), José Manuel Soria, (unknown), E. Moreno, (unknown), Jorge Sierra, (unknown), (unknown), Javier Briones	0
2	Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil 2024 ·Transplantation and Cellular Therapy ·Albert Esquirol, María Pascual, Juan Montoro, José Luís Piñana, Christelle Ferrá, (unknown), Irene García‐Cadenas, Aitana Balaguer‐Roselló, Ariadna Pérez, (unknown), (unknown), (unknown), Juan Carlos Hernández‐Boluda, (unknown), Rafael Hernani, Jaime Sanz, Carlos Solano, Jorge Sierra, Rodrigo Martino	0
3	Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation 2024 ·European Journal Of Haematology ·(unknown), Irene García‐Cadenas, Albert Esquirol, (unknown), (unknown), (unknown), Silvana Saavedra, (unknown), A Caballero, (unknown), Jordi F. López, Ana Muntañola, Annalisa Paviglianiti, (unknown), Jorge Sierra, Javier Briones, Rodrigo Martino	1
4	mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect 2023 ·Leukemia Research ·(unknown), (unknown), (unknown), Esther Moga, Sílvia Vidal, (unknown), (unknown), (unknown), (unknown), (unknown), Iria González, Joaquín López‐Contreras, Albert Esquirol, Jorge Sierra, Rodrigo Martino, Irene García‐Cadenas	2
5	Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe 2022 ·Blood Advances ·Hanadi Rafii, Annalisa Ruggeri, Chantal Kenzey, Jaime Sanz, (unknown), Albert Esquirol, Gérard Michel, Patrice Chevallier, Marie‐Thérèse Rubio, Jan J. Cornelissen, Mauricette Michallet, Fernanda Volt, Monica M. Rivera‐Franco, Graziana Maria Scigliuolo, Barbara Cappelli, Vanderson Rocha, Éliane Gluckman	1
6	mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients 2022 ·Supportive Care in Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Albert Esquirol, Iria González, Joaquín López‐Contreras, Jorge Sierra, Rodrigo Martino, Irene García‐Cadenas	3
7	Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Español de Trasplante Hematopoyético (GETH) 2021 ·Transfusion and Apheresis Science ·Joan Cid, Silvia Monsalvo, (unknown), Cristina Pascual, (unknown), Miriam López-Parra, (unknown), (unknown), Albert Esquirol, Isabel Sánchez‐Ortega, (unknown), (unknown), Carmen Martı́nez, Montserrat Rovira, Pedro Marı́n, Miquel Lozano	8
8	Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide 2021 ·Bone Marrow Transplantation ·Albert Esquirol, María Pascual, Mi Kwon, Ariadna Pérez, Rocío Parody, Christelle Ferrá, Irene García‐Cadenas, (unknown), Nieves Dorado, Rafael Hernani, Isabel Sánchez‐Ortega, Anna Torrent, Jorge Sierra, Rodrigo Martino, (unknown)	42
9	Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis 2020 ·Leukemia & lymphoma ·María Laura Fox, Irene García‐Cadenas, Ariadna Pérez, Guillermo Villacampa, José Luís Piñana, Guillermo Ortí, Juan Montoro, Elisa Roldán, Anna Bosch, Rodrigo Martino, Olga Salamero, Silvana Saavedra, Juan Carlos Hernández‐Boluda, Albert Esquirol, (unknown), Jaime Sanz, Carlos Solano, Francesc Bosch, Pere Barba, David Valcárcel	2
10	Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients 2019 ·European Journal Of Haematology ·(unknown), Ana Garrido, (unknown), Elena Bussaglia, Marta Pratcorona, (unknown), Ignasi Gich, Montserrat Hoyos, Albert Esquirol, Irene García‐Cadenas, Salut Brunet, Rodrigo Martino, Jorge Sierra, Josep Nomdedéu	6
11	Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy 2018 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), Carolina Cuéllar‐García, (unknown), (unknown), (unknown), (unknown), Salut Brunet, Javier Briones, (unknown), Albert Esquirol, Miquel Granell, Silvana Saavedra, Josep Nomdedéu, Jorge Sierra, Rodrigo Martino, Carol Moreno	2
12	Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting 2018 ·Medical Oncology ·(unknown), Josè Antonio Pérez-Simón, Mats Remberger, Teresa Caballero‐Velázquez, Rodrigo Martino, José Luís Piñana, Olle Ringdén, Albert Esquirol, Lucía López‐Corral, (unknown), Oriana López‐Godino, Jordi Sierra, Dolores Caballero, Per Ljungman, Lourdes Vázquez, Hans Hägglund	12
13	CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome 2018 ·Biology of Blood and Marrow Transplantation ·Pere Barba, Rodrigo Martino, Qin Zhou, Christina Cho, Hugo Castro‐Malaspina, Sean M. Devlin, Albert Esquirol, Sergio Giralt, Ann A. Jakubowski, Dolores Caballero, Molly Maloy, Esperanza B. Papadopoulos, José Luís Piñana, María Laura Fox, Francisco J. Márquez‐Malaver, David Valcárcel, Carlos Solano, Lucía López‐Corral, Jorge Sierra, Miguel‐Angel Perales	16
14	Do Patients and Physicians Agree When They Assess Quality of Life? 2017 ·Biology of Blood and Marrow Transplantation ·Anna Barata, Rodrigo Martino, Ignasi Gich, Irene García‐Cadenas, Eugènia Abella, Pere Barba, Javier Briones, Salut Brunet, Albert Esquirol, Francesc García‐Pallarols, Ana Garrido, (unknown), (unknown), (unknown), Silvana Novelli, Blanca Sánchez‐González, David Valcárcel, Jordi Sierra	6
15	Allogeneic hematopoietic stem cell transplantation for non-Hodgkin’s lymphomas: a retrospective analysis of 77 cases 2017 ·Annals of Hematology ·(unknown), Silvana Novelli, (unknown), Irene García‐Cadenas, A Caballero, Rodrigo Martino, Albert Esquirol, Javier Briones, Jorge Sierra	3
16	Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies 2017 ·Bone Marrow Transplantation ·Albert Esquirol, María Pascual, (unknown), José Luís Piñana, Christelle Ferrá, (unknown), (unknown), (unknown), Rodrigo Martino, Jorge Sierra	13
17	Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation 2016 ·Bone Marrow Transplantation ·Mohamed A. Kharfan‐Dabaja, Rocío Parody, Janelle Perkins, Oriana López‐Godino, Lucía López‐Corral, Lourdes Vázquez, Dolores Caballero, José Falantes, J. Shapiro, Guillermo Ortí, Pere Barba, David Valcárcel, Albert Esquirol, Rodrigo Martino, José Luís Piñana, Carlos Solano, Athanasios Tsalatsanis, Joseph Pidala, Claudio Anasetti, Josè Antonio Pérez-Simón	8
18	Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease 2016 ·Bone Marrow Transplantation ·Irene García‐Cadenas, (unknown), Rodrigo Martino, Albert Esquirol, Pere Barba, Silvana Novelli, Guillermo Ortí, Javier Briones, Salut Brunet, David Valcárcel, Jorge Sierra	38
19	Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab 2015 ·Bone Marrow Transplantation ·Irene García‐Cadenas, (unknown), Rodrigo Martino, Pere Barba, Albert Esquirol, Silvana Novelli, Guillermo Ortí, Ana Garrido, (unknown), (unknown), Miquel Granell, Javier Briones, Salut Brunet, Ferrán Navarro, Isabel Ruíz-Camps, Núria Rabella, David Valcárcel, Jorge Sierra	45
20	Foetal-neonatal alloimmune thrombocytopenia due to anti-HPA-2b antibodies present in the serum of a mother initially mistyped as HPA-1a negative. 2012 ·PubMed ·Albert Esquirol, Carmen Canals, (unknown), (unknown), (unknown), (unknown), (unknown), Núria Nogués, Eduardo Muñiz‐Díaz	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact